Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2022

View Archived Issues

Modulating CYTOR promotes myogenesis in aging

TGFBR3L modulates FSH activity and fertility

Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies

Compact cell classifiers packaged into AAV vectors for precision tumor cell targeting

MRSA superbug has prickly origins

French researchers patent new antibacterial compounds

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Chinese researchers describe new GLP-1 receptor agonists

Life Biosciences to accelerate R&D activities on aging-related programs

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Discovery of novel bergenin derivatives as immunosuppressive agents

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies

Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206

SalioGen obtains funding to advance research into genetic therapy for cystic fibrosis

Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies

Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes

JUVA-019 enters preclinical development for inflammatory disease

LA-PAMAM/pmiR-218 polyplex as potential targeted gene therapy against HCC

Enanta expands respiratory virology program with EDP-323 for RSV

Regulating fibrin-neutrophil interaction for controlling periodontitis

Unity Biotechnology eyes IND-enabling studies with pipeline programs in 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...